SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-092688
Filing Date
2022-08-19
Accepted
2022-08-18 20:04:12
Documents
1
Group Members
CASEY M. TANSEYJONATHAN D. ROOTPRESIDIO MANAGEMENT GROUP X, L.L.C.USVP X AFFILIATES, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2224140-1_sc13da.htm SC 13D/A 141649
  Complete submission text file 0001104659-22-092688.txt   143358
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2735 SAND HILL ROAD MENLO PARK CA 94025 650-854-9080
US VENTURE PARTNERS X LP (Filed by) CIK: 0001440514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91982 | Film No.: 221178664
SIC: 2834 Pharmaceutical Preparations